Over in the Discord we were discussing how all sequencing companies except Illumina are losing money again. This got me thinking, ranked by profir/loss who would be doing the best/worst. Clearly Illumina would be no. 1.
But where would others lie… a small startup like Acorn Genetics who have probably raised less than a few million, is probably doing pretty well in comparison to Oxford Nanopore, who have deployed billions!
So I decided to start this exercise with Oxford Nanopore, this is an easy target as being a UK company all the pre-IPO accounts are available at companies house.